E-Articles - Health and Fitness

Cardiovascular disease, strokes, and peripheral vascular disease are all very expensive conditions to treat in our technologically sophisticated healt

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

h care system. These conditions already occupy some of the top slots when it comes to where our health care dollar are spent. So imagine what is going

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

to happen now that the rates of diabetes have doubled (with no end in sight).

So, this epidemic of diabetes and pre-diabetes is not just a health car

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

e issue that burdens individuals and their families living with the disease. It is a looming societal problem that threatens to bankrupt our already f

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

agile health care system. It could cause health care insurance premiums to escalate even further, impacting not only employers who provide coverage, b

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

t also public payors, like Medicaid and Medicare.

An article published in the New York Times January 31, 2007 by Richard P?rez-Pe?a declares, "One in

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

Eight Adults in the City Has Diabetes, a Study Finds". That is 12.5% of the population or 700,000 people. Lest you feel relieved that you don’t live

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

here, let me remind you that the rest of the country is not all that far behind. Overall, about 10.3% of Americans have diabetes and about a quarter o

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

f them don’t know it (yet).

An additional 24% of adults in NY (and in the rest of the country) have abnormally high blood sugars that have not yet re

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ched diabetic levels. This condition is known as pre-diabetes.

Not too many years ago, the diabetes rate was 6%. But our self-indulgent ways have ca

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ght up with us. Too little exercise, too many calories plus too much stress adds up to an epidemic of obesity, particularly abdominal obesity. Abdomin

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

al obesity, especially dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

k">visceral obesity, is linked to the development of Type 2 diabetes in genetically predisposed individuals.

It’s just a “touch of sugar.” Why al

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

l the concern? Because diabetes and it precursor, pre-diabetes, are the most familiar manifestations of a constellation of metabolic changes, known as

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

cardiometabolic syndrome. Other manifestations of this syndrome are high blood pressure, dyslipidemia ((high triglycerides) and low HDL (“good”) chole

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

terol)), clotting abnormalities, and problems with inflammation. People with cardiometabolic syndrome, even if they haven’t yet developed full-blown d

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

iabetes, have an increased risk of heart attacks and strokes.

It is time to get deadly serious about doing something about prevention. We need to rap

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

dly move to institutionalize regular exercise programs in school and at work. And we need affordable, easily accessible healthy eating options. That m

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

eans we must be willing to regulate, legislate, and maybe even implement taxes (oh, oh, the tax word!) that can get us to where we need to be. Failure

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

to do something now will almost certainly result in huge adverse financial consequences that will ripple through society in the not too distant future

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-article.org.ua/article/240334/e-article-Diabetes-Epidemic-Threatens-Health-Care-System.html">Diabetes Epidemic Threatens Health Care System</a>

BB link (for phorums):
[url=http://www.e-article.org.ua/article/240334/e-article-Diabetes-Epidemic-Threatens-Health-Care-System.html]Diabetes Epidemic Threatens Health Care System[/url]

In any type of business, one of the most important aspects is your employee morale. While this may sound like some type of HR buzzword, it is a vital piece of the puzzle. Unhappy workers produce less work. Not to mention, the quality of the work usually leaves something to be desired. Happy workers produce more quality work.

Negotiation made simple indeed, no this was not an actual book I bought this week, although there is no doubt someone has written such a book. The fact is that negotiation is not so simple and until you have done lots of negotiation, you really are not that good at it and it is not so simple. You see, there are so many little tricks that are used in negotiation.

What will we experience within the first 24 hours after we are dead ? It's not what most people in America think. Even if you do not believe in God or the Bible you will find this very interesting.

Tags

Links

E-Articles - Diabetes Epidemic Threatens Health Care System

Related Articles: